Glenmark Pharmaceuticals Sees Surge in Active Put Options with 3,628 Contracts at Rs 2100 Strike

Glenmark Pharmaceuticals Ltd. has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The company, operating within the Pharmaceuticals & Biotechnology industry, has seen significant trading activity with two notable put options set to expire on July 31, 2025.
The put option with a strike price of Rs 2000 recorded 3,431 contracts traded, generating a turnover of approximately Rs 444.04 lakhs, while the Rs 2100 strike price option saw 3,628 contracts traded, resulting in a turnover of around Rs 919.87 lakhs. The open interest for these options stands at 1,460 and 1,351 contracts, respectively, indicating a robust interest among traders.

Glenmark's underlying stock value reached a new 52-week and all-time high of Rs 2094.4 today, reflecting a strong performance that outpaced its sector by 9.27%. The stock has been on a positive trajectory, gaining 15.15% over the last two days, and opened with a notable gap up of 10%. It has consistently traded above its moving averages across various time frames, showcasing solid momentum.

With a market capitalization of Rs 53,763 crore, Glenmark Pharmaceuticals continues to demonstrate liquidity, with a delivery volume of 9.28 lakhs on July 10, up 72.44% from its five-day average. Overall, the activity in Glenmark's put options highlights a significant engagement in the stock, reflecting the current market dynamics without delving into future implications.